IMGN - ImmunoGen, Inc.
Close
31.23
0 0%
Share volume: 0
Last Updated: Fri 09 Feb 2024 10:00:01 PM CET
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
$31.23
0.00
0.00%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
Report Date | 2022-05-06 | 2022-08-01 | 2022-11-04 | 2023-03-01 | 2023-04-28 | 2023-07-31 | 2023-11-02 | |
Total revenue | 38.078 M | 14.162 M | 15.375 M | 41.167 M | 49.869 M | 83.153 M | 113.425 M | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 176.000 K | 626.000 K | 909.000 K | 2.155 M | |
Gross profit | 38.078 M | 14.162 M | 15.375 M | 40.991 M | 49.243 M | 82.244 M | 111.270 M | |
-62.81% | 8.57% | 166.61% | 20.13% | 67.02% | 35.29% | |||
Operating expenses | 60.930 M | 75.215 M | 92.804 M | 100.550 M | 91.636 M | 86.433 M | 85.314 M | |
Selling general and admin | 16.648 M | 23.793 M | 33.623 M | 42.065 M | 40.016 M | 36.356 M | 37.744 M | |
Research and development | 44.282 M | 51.422 M | 59.181 M | 58.485 M | 51.620 M | 50.077 M | 47.570 M | |
Total expenses | 60.930 M | 75.215 M | 92.804 M | 100.726 M | 92.262 M | 87.342 M | 87.469 M | |
23.44% | 23.38% | 8.54% | -8.40% | -5.33% | 0.15% | |||
Operating income | -22.852 M | -61.053 M | -77.429 M | -59.559 M | -42.393 M | -4.189 M | 25.956 M | |
Ebit | -22.852 M | -61.053 M | -77.429 M | -59.559 M | -42.393 M | -4.189 M | 25.956 M | |
Pretax income | -24.145 M | -62.021 M | -77.755 M | -57.790 M | -41.014 M | -3.371 M | 29.582 M | |
156.87% | 25.37% | -25.68% | -29.03% | -91.78% | -977.54% | |||
Income tax | 0.000 | 0.000 | 0.000 | 1.218 M | 0.000 | 877.000 K | -1.166 M | |
Net income basic | -24.145 M | -62.021 M | -77.755 M | -59.008 M | -41.014 M | -4.248 M | 30.748 M | |
-156.87% | -25.37% | 24.11% | 30.49% | 89.64% | 823.82% | |||
Net income | -24.145 M | -62.021 M | -77.755 M | -59.008 M | -41.014 M | -4.248 M | 30.748 M | |
-156.87% | -25.37% | 24.11% | 30.49% | 89.64% | 823.82% |